Benzinga | Aug 3, 2021 10:34AM EDT

Goldman Sachs Maintains Neutral on IDEXX Laboratories, Raises Price Target to $610

Goldman Sachs maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises the price target from $550 to $610.